Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults

Clinical Trial ID NCT01095224

PubWeight™ 1.71‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01095224

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CD8+ T cell efficacy in vaccination and disease. Nat Med 2008 3.20
2 Controlling the HIV/AIDS epidemic: current status and global challenges. Front Immunol 2012 0.92
3 Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1). BioDrugs 2009 0.80
4 Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083. J Infect Dis 2015 0.79
Next 100